Steven Michael Blum, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood | 1 | 2024 | 596 | 0.790 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2021 | 219 | 0.680 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 49 | 0.580 |
Why?
|
Myocarditis | 1 | 2024 | 792 | 0.550 |
Why?
|
Prostatic Hyperplasia | 1 | 2018 | 521 | 0.450 |
Why?
|
Myocardium | 1 | 2024 | 4746 | 0.380 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2527 | 0.340 |
Why?
|
Neoplasms | 5 | 2024 | 22140 | 0.300 |
Why?
|
Ventricular Myosins | 1 | 2024 | 65 | 0.240 |
Why?
|
Stomach Neoplasms | 2 | 2024 | 1457 | 0.220 |
Why?
|
Drug Compounding | 2 | 2020 | 245 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6919 | 0.190 |
Why?
|
Pharmaceutic Aids | 1 | 2020 | 7 | 0.190 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3873 | 0.180 |
Why?
|
Bile Acids and Salts | 1 | 2022 | 394 | 0.180 |
Why?
|
Autoantigens | 1 | 2024 | 888 | 0.170 |
Why?
|
Troponin I | 1 | 2024 | 652 | 0.170 |
Why?
|
Troponin T | 1 | 2024 | 780 | 0.170 |
Why?
|
Microsatellite Repeats | 1 | 2021 | 782 | 0.160 |
Why?
|
Microscopy | 1 | 2024 | 904 | 0.160 |
Why?
|
Exosomes | 1 | 2023 | 424 | 0.160 |
Why?
|
Melanoma | 3 | 2022 | 5694 | 0.160 |
Why?
|
International Classification of Diseases | 1 | 2024 | 915 | 0.160 |
Why?
|
Microsatellite Instability | 1 | 2021 | 716 | 0.150 |
Why?
|
Hypertension | 1 | 2018 | 8536 | 0.150 |
Why?
|
Peritoneal Neoplasms | 1 | 2024 | 710 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 240 | 0.150 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1783 | 0.140 |
Why?
|
Immunity | 1 | 2023 | 996 | 0.140 |
Why?
|
Hydronephrosis | 1 | 2018 | 271 | 0.130 |
Why?
|
Cell Lineage | 1 | 2024 | 2548 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2024 | 2549 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1052 | 0.120 |
Why?
|
Fibroblasts | 1 | 2024 | 4137 | 0.110 |
Why?
|
Leukocyte Count | 1 | 2018 | 1597 | 0.110 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 497 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2024 | 2726 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2451 | 0.110 |
Why?
|
Prescription Drugs | 1 | 2020 | 631 | 0.110 |
Why?
|
Patient Admission | 1 | 2019 | 1365 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1234 | 0.100 |
Why?
|
Heart | 1 | 2024 | 4431 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4744 | 0.090 |
Why?
|
Brain | 1 | 2018 | 27092 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3840 | 0.090 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1086 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2756 | 0.080 |
Why?
|
Immunotherapy | 2 | 2022 | 4642 | 0.080 |
Why?
|
MicroRNAs | 1 | 2023 | 3758 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2024 | 22174 | 0.070 |
Why?
|
Transcription Factors | 2 | 2024 | 12099 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3301 | 0.070 |
Why?
|
Humans | 18 | 2024 | 761208 | 0.070 |
Why?
|
Clinical Competence | 1 | 2020 | 4788 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3354 | 0.060 |
Why?
|
Antibodies, Fungal | 1 | 2003 | 34 | 0.060 |
Why?
|
Aged | 5 | 2024 | 169288 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2024 | 314 | 0.050 |
Why?
|
Peritoneum | 1 | 2024 | 225 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 212 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12976 | 0.050 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5425 | 0.050 |
Why?
|
Ascites | 1 | 2023 | 338 | 0.050 |
Why?
|
Male | 8 | 2024 | 360693 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 289 | 0.050 |
Why?
|
Mutation | 2 | 2024 | 30002 | 0.050 |
Why?
|
Female | 7 | 2024 | 392544 | 0.050 |
Why?
|
Cadherins | 1 | 2024 | 902 | 0.040 |
Why?
|
Excipients | 1 | 2019 | 98 | 0.040 |
Why?
|
Young Adult | 2 | 2022 | 59221 | 0.040 |
Why?
|
raf Kinases | 1 | 2016 | 118 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1490 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2024 | 1165 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11701 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9416 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20588 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1567 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 16952 | 0.030 |
Why?
|
Antigens, CD | 1 | 2024 | 4009 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23416 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2003 | 2667 | 0.030 |
Why?
|
History, 20th Century | 1 | 2020 | 2765 | 0.030 |
Why?
|
Lymphocytes | 1 | 2020 | 2603 | 0.030 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2016 | 619 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 1240 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 736 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2003 | 1920 | 0.020 |
Why?
|
ras Proteins | 1 | 2016 | 1055 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1668 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.020 |
Why?
|
Risk | 1 | 2023 | 9616 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4015 | 0.020 |
Why?
|
Crohn Disease | 1 | 2003 | 2278 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36415 | 0.020 |
Why?
|
Tumor Burden | 1 | 2016 | 1892 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80674 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8530 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2545 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1847 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2455 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2016 | 2881 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3763 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 220853 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2024 | 4822 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9327 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4909 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3265 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21365 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 11856 | 0.010 |
Why?
|
Animals | 3 | 2024 | 168079 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81326 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64681 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7571 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9187 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11067 | 0.010 |
Why?
|
Serologic Tests | 1 | 2003 | 381 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13511 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16575 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24021 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39957 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18220 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58952 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 74239 | 0.010 |
Why?
|
Adult | 1 | 2022 | 221119 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39126 | 0.000 |
Why?
|
Prospective Studies | 1 | 2003 | 54435 | 0.000 |
Why?
|